TUCSON, AZ--(MARKET WIRE)--Jul 24, 2007 -- CDEX, Inc. (OTC BB:CEXI.OB - News) announces that it has increased sensitivity and added scan capability to its hand-held methamphetamine detection device (ID2) in preparation for a second round of beta testing scheduled to begin at multiple locations in August 2007. In response to market testing, improvements made to the ID2 include a continuous scan capability, increased sensitivity, a greater scan area, a targeting device and a range indictor to assist the operator in detector positioning. The increased sensitivity allows the identification of trace quantities of methamphetamine on most surfaces including skin and clothing.
